Do you support dupilumab for all of the AD spectrum conditions if moderate-to-severe and failing?
Featuring Peter Lio, MD |

Clinical Assistant Professor of Dermatology Pediatrics 
Northwestern University Feinberg School of Medicine
Chicago, IL

| Published July 07, 2021
Loading...
Loading...
Loading...
Dermsquared

The leading platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2023 dermsquared | All Rights Reserved